BerGenBio ASA
Stock Forecast, Prediction & Price Target
BerGenBio ASA Financial Estimates
BerGenBio ASA Revenue Estimates
BerGenBio ASA EBITDA Estimates
BerGenBio ASA Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| NOK774K N/A | NOK389K -49.74% | NOK354K -8.99% | Avg: NOK169.51K Low: NOK169.51K High: NOK169.51K avg. -52.11% | Avg: NOK117.30K Low: NOK117.30K High: NOK117.30K avg. -30.80% | Avg: NOK81.17K Low: NOK81.17K High: NOK81.17K avg. -30.80% | Avg: NOK18.7M Low: NOK18.7M High: NOK18.7M avg. 22936.93% |
Net Income
% change YoY
| NOK-309.41M N/A | NOK-298.60M 3.49% | NOK-190.40M 36.23% | Avg: NOK-227.28M Low: NOK-1.17T High: NOK-8.48B avg. -19.37% | Avg: NOK-337.6M Low: NOK-8.68B High: NOK-8.68B avg. -48.53% | Avg: NOK-10.82B Low: NOK-10.82B High: NOK-10.82B avg. -3105.16% | Avg: NOK-12.06B Low: NOK-12.06B High: NOK-12.06B avg. -11.50% |
EBITDA
% change YoY
| NOK-307.99M N/A | NOK-300.91M 2.29% | NOK-189.6M 36.99% | Avg: NOK-169.51K Low: NOK-169.51K High: NOK-169.51K avg. 99.91% | Avg: NOK-117.30K Low: NOK-117.30K High: NOK-117.30K avg. 30.80% | Avg: NOK-81.17K Low: NOK-81.17K High: NOK-81.17K avg. 30.80% | Avg: NOK-18.7M Low: NOK-18.7M High: NOK-18.7M avg. -22936.93% |
EPS
% change YoY
| -$3.04 N/A | -$3.37 -10.85% | -$13.3 -294.65% | Avg: -$278.64 Low: -$822 High: -$5.93 avg. -1995.06% | Avg: -$6.07 Low: -$6.07 High: -$6.07 avg. 97.82% | Avg: -$7.56 Low: -$7.56 High: -$7.56 avg. -24.54% | Avg: -$8.43 Low: -$8.43 High: -$8.43 avg. -11.50% |
Operating Expenses
% change YoY
| NOK315.23M N/A | NOK306.02M -2.92% | NOK192.17M -37.20% | Avg: NOK11.38M Low: NOK11.38M High: NOK11.38M avg. -94.07% | Avg: NOK7.87M Low: NOK7.87M High: NOK7.87M avg. -30.80% | Avg: NOK5.45M Low: NOK5.45M High: NOK5.45M avg. -30.80% | Avg: NOK1.25B Low: NOK1.25B High: NOK1.25B avg. 22936.93% |
FAQ
What is BerGenBio ASA stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -796.14% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -1.17T, average is -227.28M and high is -8.48B.
What is BerGenBio ASA stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5705.80% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is NOK169.51K, average is NOK169.51K and high is NOK169.51K.
What is BerGenBio ASA stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -483.32% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$822, average is -$278.64 and high is NOK-5.93.